Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,761
archived clinical trials in
Osteoporosis

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Wichita Falls, TX
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Norfolk, VA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Richmond, VA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Renton, WA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Seattle, WA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Spokane, WA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Tacoma, WA
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Madison, WI
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Milwaukee, WI
A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
A Prospective, Open-Label, Multi-Center, Two-Part Study to Investigate Patient Satisfaction With Monthly Dosed Ibandronate Therapy in Women With Post-Menopausal Osteoporosis or Osteopenia Transitioned From Once-Weekly Alendronate or Risendronate
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Status: Enrolling
Updated:  8/15/2016
University of Missouri, Department of Internal Medicine
mi
from
Columbia, MO
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
Status: Enrolling
Updated: 8/15/2016
University of Missouri, Department of Internal Medicine
mi
from
Columbia, MO
Click here to add this to my saved trials
Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur
Early Effects of PTH on the Proximal Femur
Status: Enrolling
Updated:  11/22/2016
Helen Hayes Hospital
mi
from
West Haverstraw, NY
Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur
Early Effects of PTH on the Proximal Femur
Status: Enrolling
Updated: 11/22/2016
Helen Hayes Hospital
mi
from
West Haverstraw, NY
Click here to add this to my saved trials
Testosterone and Alendronate in Hypogonadal Men
Testosterone and Alendronate in Hypogonadal Men
Status: Enrolling
Updated:  11/30/2016
Massachusetts General Hospital
mi
from
Boston, MA
Testosterone and Alendronate in Hypogonadal Men
Testosterone and Alendronate in Hypogonadal Men
Status: Enrolling
Updated: 11/30/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Status: Enrolling
Updated:  11/30/2016
Massachusetts General Hospital
mi
from
Boston, MA
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Status: Enrolling
Updated: 11/30/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
Research Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
Status: Enrolling
Updated:  12/1/2016
NYU Center for Biomedical Imaging
mi
from
New York, NY
Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
Research Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
Status: Enrolling
Updated: 12/1/2016
NYU Center for Biomedical Imaging
mi
from
New York, NY
Click here to add this to my saved trials
The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa
The Role of PTH in Low Bone Mass in Anorexia Nervosa
Status: Enrolling
Updated:  1/9/2017
Massachusetts General Hospital
mi
from
Boston, MA
The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa
The Role of PTH in Low Bone Mass in Anorexia Nervosa
Status: Enrolling
Updated: 1/9/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study
Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study
Status: Enrolling
Updated:  2/8/2017
University of Mississippi Medical Center
mi
from
Jackson, MS
Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study
Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study
Status: Enrolling
Updated: 2/8/2017
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Santa Maria, CA
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Santa Maria, CA
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
South Lake Tahoe, CA
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
South Lake Tahoe, CA
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Lakewood, CO
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Gainesville, GA
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Bethesda, MD
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Detroit, MI
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Albuquerque, NM
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Akron, OH
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Bend, OR
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
Clinical Research Facility
mi
from
Duncansville, PA
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  4/11/2017
mi
from
Vancouver,
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
A Multicenter, Double-blind, Randomized Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 4/11/2017
mi
from
Vancouver,
Click here to add this to my saved trials
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated:  4/12/2017
Clinical Research Facility
mi
from
NMiami, FL
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated: 4/12/2017
Clinical Research Facility
mi
from
NMiami, FL
Click here to add this to my saved trials
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated:  4/12/2017
Clinical Research Facility
mi
from
Atlanta, GA
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated: 4/12/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated:  4/12/2017
Clinical Research Facility
mi
from
Bethesda, MD
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated: 4/12/2017
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated:  4/12/2017
Clinical Research Facility
mi
from
Lakewood, CO
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated: 4/12/2017
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated:  4/12/2017
mi
from
Buenos Aires,
Twenty Four Month Extension Study of BA058-05-003
An Extension Study to Evaluate 24 Months of Standard-of-Care Osteoporosis Management Following Completion of 18 Months of BA058 (Abaloparatide) or Placebo Treatment in Protocol BA058-05-003
Status: Enrolling
Updated: 4/12/2017
mi
from
Buenos Aires,
Click here to add this to my saved trials
Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study
Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study
Status: Enrolling
Updated:  4/20/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study
Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study
Status: Enrolling
Updated: 4/20/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study
Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study
Status: Enrolling
Updated:  4/20/2017
Washington Hospital Center
mi
from
Washington, D.C.,
Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study
Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) Study
Status: Enrolling
Updated: 4/20/2017
Washington Hospital Center
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Trial of Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Status: Enrolling
Updated:  4/20/2017
University of Maryland School of Medicine
mi
from
Baltimore, MD
Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Trial of Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Status: Enrolling
Updated: 4/20/2017
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bindex Ultrasonometer for Osteoporosis Diagnostics
Validation of Bindex Bone Ultrasonometer for Osteoporosis Diagnostics
Status: Enrolling
Updated:  5/16/2017
HealthEast Clinic
mi
from
Saint Paul, MN
Bindex Ultrasonometer for Osteoporosis Diagnostics
Validation of Bindex Bone Ultrasonometer for Osteoporosis Diagnostics
Status: Enrolling
Updated: 5/16/2017
HealthEast Clinic
mi
from
Saint Paul, MN
Click here to add this to my saved trials
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated:  7/13/2017
Clinical Research Facility
mi
from
Loma Linda, CA
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated: 7/13/2017
Clinical Research Facility
mi
from
Loma Linda, CA
Click here to add this to my saved trials
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated:  7/13/2017
Clinical Research Facility
mi
from
Lakewood, CO
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated: 7/13/2017
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated:  7/13/2017
Clinical Research Facility
mi
from
Omaha, NE
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated: 7/13/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated:  7/13/2017
Clinical Research Facility
mi
from
Livingston, NJ
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated: 7/13/2017
Clinical Research Facility
mi
from
Livingston, NJ
Click here to add this to my saved trials
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated:  7/13/2017
Clinical Research Facility
mi
from
Portland, OR
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated: 7/13/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated:  7/13/2017
mi
from
Liege,
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Double-blind, Partially Randomized, Parallel Group, Multicenter Study to Assess the Efficacy and Safety of 100 mg and 150 mg Monthly Oral Ibandronate in Women With Postmenopausal Osteoporosis Having Completed the Phase III Oral Ibandronate Trial BM16549
Status: Enrolling
Updated: 7/13/2017
mi
from
Liege,
Click here to add this to my saved trials
Cyclic Versus Daily Teriparatide on Bone Mass
Cyclic Versus Daily Teriparatide on Bone Mass
Status: Enrolling
Updated:  8/9/2017
Helen Hayes Hospital
mi
from
West Haverstraw, NY
Cyclic Versus Daily Teriparatide on Bone Mass
Cyclic Versus Daily Teriparatide on Bone Mass
Status: Enrolling
Updated: 8/9/2017
Helen Hayes Hospital
mi
from
West Haverstraw, NY
Click here to add this to my saved trials
The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab
The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab
Status: Enrolling
Updated:  8/30/2017
Helen Hayes Hospital
mi
from
West Haverstraw, NY
The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab
The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab
Status: Enrolling
Updated: 8/30/2017
Helen Hayes Hospital
mi
from
West Haverstraw, NY
Click here to add this to my saved trials
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
The Effect of Bisphosphonate on Bone Mass and Bone Turnover in Elderly, Postmenopausal Women With Breast Cancer Following Initiation of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  9/12/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
The Effect of Bisphosphonate on Bone Mass and Bone Turnover in Elderly, Postmenopausal Women With Breast Cancer Following Initiation of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 9/12/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
A Randomized, Parallel-Group, Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated:  9/27/2017
Radius Health, Inc.
mi
from
Cambridge, MA
Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
A Randomized, Parallel-Group, Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
Status: Enrolling
Updated: 9/27/2017
Radius Health, Inc.
mi
from
Cambridge, MA
Click here to add this to my saved trials
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Status: Enrolling
Updated:  9/29/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Status: Enrolling
Updated: 9/29/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Spine Quantitative Computed Tomography (QCT)
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Status: Enrolling
Updated:  9/29/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Spine Quantitative Computed Tomography (QCT)
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Status: Enrolling
Updated: 9/29/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
T-cell Depleted Alternative Donor Transplantation
A Phase II Study Using the CliniMACS® Device for CD34+ Cell Selection and T Cell Depletion for Graft-versus-Host Disease Prophylaxis in Alternative Donor Stem Cell Transplant Recipients
Status: Enrolling
Updated:  10/8/2017
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
T-cell Depleted Alternative Donor Transplantation
A Phase II Study Using the CliniMACS® Device for CD34+ Cell Selection and T Cell Depletion for Graft-versus-Host Disease Prophylaxis in Alternative Donor Stem Cell Transplant Recipients
Status: Enrolling
Updated: 10/8/2017
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials